九强新闻

Abbott and BSBE Sign Contract to Deepen Local Cooperation

Published:2021-05-13

Source:BSBE

On May 13, 2021, during the annual Clinical Laboratory Medicine meeting of the Chinese Medical Doctor Association in Zhuhai, Guangdong, the world’s leading medical and healthcare company Abbott signed an agreement with Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) to cooperate in producing special reagents for Abbott’s automated diagnostic system. After Abbott and BSBE’s cooperation on Abbott ARCHITECT system special reagents in 2013, the signing of the new agreement is another important milestone for Abbott to accelerate localization and to continue to promote the accessibility of its cutting-edge diagnostic products in China.


Abbott and BSBE Signing Agreement
(From left to right) Chen Jianzhong, Vice President of Abbott Core Diagnostics, and Zou Zuojun, Chairman of BSBE.



This deepening cooperation will help Abbott to provide Chinese customers with more comprehensive biochemical testing menus, as well as personalized diagnostic solutions that are simple to operate and excellent in performance with comprehensive after-sales service.


Gu Linlin, marketing director of Abbott Core Diagnostics, and Zhang Yi, deputy general manager of BSBE, signed the cooperation agreement. Chen Jianzhong, vice president of Abbott’s core diagnostics, Zou Zuojun, chairman of BSBE, and Professor Wang Chuanxin, appointed chairman of the Chinese Medical Association Laboratory Medicine Branch and the vice chairman of the Chinese Medical Doctor Association Physician Branch, witnessed the signing of the agreement.


The Signing Ceremony of Abbott and BSBE


(From left to right) Gu Linlin, Marketing Director of Abbott Core Diagnostics, Chen Jianzhong, Vice President of Abbott Core Diagnostics, Professor Wang Chuanxin, Appointed Chairman of the Chinese Medical Association Laboratory Medicine Branch and the Vice Chairman of the Chinese Medical Doctor Association Physician Branch, Zou Zuojun, Chairman of BSBE, Zhang Yi, Deputy General Manager of BSBE


Professor Wang Chuanxin, Appointed Chairman of the Chinese Medical Association Laboratory Medicine Branch and the Vice Chairman of the Chinese Medical Doctor Association Physician Branch, expressed his warm congratulations

Professor Wang Chuanxin, appointed Chairman of the Chinese Medical Association Laboratory Medicine Branch and the Vice Chairman of the Chinese Medical Doctor Association Physician Branch, expressed his warm congratulations on the signing of the cooperation agreement between Abbott and BSBE. Professor Wang Chuanxin said: "I believe that the deepening of cooperation between Abbott and BSBE can further promote the development of China's in vitro diagnostic industry, provide more medical institutions and patients with testing items that are more suitable for the Chinese population, and deliver more efficient and accurate test results."


Speech by Chen Jianzhong, Vice President of Abbott Core Diagnostics

Chen Jianzhong, Vice President of Abbott Core Diagnostics, said: “As a leader in the field of diagnostics, Abbott always pays attention to the medical and healthcare needs of the Chinese market. We hope to continue to bring Abbott’s advanced biochemical testing innovations to Chinese hospitals and patients through deepening localization cooperation, and to continue to promote improvement of laboratory efficiency and patient satisfaction. In the future, Abbott will also actively explore more possible cooperation models with local partners to assist in “quality” and quantity” development of Chinese laboratory medicine, and contribute to the Healthy China vision. 



Zou Zuojun, Chairman of BSBE, Delivered a Speech

Zou Zuojun, Chairman of BSBE, said: “We are very pleased to work hand in hand with Abbott to accelerate the integration of healthcare in China and international cutting-edge diagnostic technology. This deepening cooperation also shows that BSBEs technique and quality control system has been endorsed by international giants, which will bring positive and stable impact on the company’s future development. At the same time, this recognition will also boost innovation in BSBE and lay an important foundation for future international market expansion of BSBE.”

After more than 20 years of continuous innovation and deep cultivation, with most complete IVD biochemical products and best product quality, BSBE has risen to become one of the most prestigious domestic companies in the medical diagnostic industry of China. BSBE supplies high-quality, versatile and diverse biochemical testing menus to Abbott’s biochemical testing platform, which will meet the multi-level needs of Chinese users and improve the customer experience.

As a leader in the global medical and healthcare field, Abbott has always believed that health is the starting point for a sustainable future and health is the foundation of everything. Abbott’s 2030 Sustainability Plan clearly states that when companies develop life-changing cutting-edge technologies and products, they must pay attention to accessibility and affordability, so that products and technologies can cover wider areas and benefit more people. Abbott always pays attention to the medical and healthcare needs of the China market and continues to bring better products to Chinese patients during its 30 years market cultivation. In the future, Abbott will actively respond to the call of the nations Healthy China 2030 Action Plan, and will work with industry partners to make cutting-edge health technologies and high-quality medical resources more accessible and prompt, and to help realize the Healthy China vision.